Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Mussetti

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|June 19, 2022
Second-line CAR T cells for lymphomasAlberto Mussetti, Anna Sureda
Blood|April 3, 2025
Prizloncabtagene autoleucel: a new CAR T cell for B-NHLAlberto Mussetti, Anna Sureda
The Lancet. Oncology|July 6, 2023
γ-Secretase inhibitors plus anti-BCMA chimeric antigen receptor T cellsAlberto Mussetti, Anna Sureda
The Lancet. Haematology|January 21, 2020
What's behind chronic graft versus host disease incidence curves?Alberto Mussetti, Anna Sureda
British Journal of Haematology|June 25, 2025
Allogeneic haematopoietic cell transplant should still be considered as a curative option for relapsed/refractory large B-cell lymphoma, including in the CAR T-cell eraFernando Molina, Anna Sureda, Alberto Mussetti
Haematologica|September 25, 2025
Enhancing myeloablative fludarabine-busulfan conditioning with total marrow irradiation in high-risk myeloid diseaseFernando Molina, Alberto Mussetti, Anna Sureda
Hematology. American Society of Hematology. Education Program|December 9, 2023
CAR T-cell therapy in aggressive lymphomas-identifying prognostic and predictive markersAlberto Mussetti, Nicole Fabbri, Anna Sureda
Current Opinion in Infectious Diseases|July 18, 2022
COVID19 in hematological patients and telemedicine: lessons learned across Europe and the USAlberto Mussetti, Zinaida Peric, Cesar Figueroa
Leukemia & Lymphoma|August 14, 2012
Effective treatment of pomalidomide in central nervous system myelomatosisAlberto Mussetti, Serena Dalto, Vittorio Montefusco
Journal of Clinical Medicine|October 29, 2020
Allogeneic Hematopoietic Transplantation for Multiple Myeloma in the New Drugs Era: A Platform to CureAlberto Mussetti, Maria Queralt Salas, Vittorio Montefusco
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|June 19, 2022
Second-line CAR T cells for lymphomasAlberto Mussetti, Anna Sureda
Blood|April 3, 2025
Prizloncabtagene autoleucel: a new CAR T cell for B-NHLAlberto Mussetti, Anna Sureda
The Lancet. Oncology|July 6, 2023
γ-Secretase inhibitors plus anti-BCMA chimeric antigen receptor T cellsAlberto Mussetti, Anna Sureda
The Lancet. Haematology|January 21, 2020
What's behind chronic graft versus host disease incidence curves?Alberto Mussetti, Anna Sureda
British Journal of Haematology|June 25, 2025
Allogeneic haematopoietic cell transplant should still be considered as a curative option for relapsed/refractory large B-cell lymphoma, including in the CAR T-cell eraFernando Molina, Anna Sureda, Alberto Mussetti
Haematologica|September 25, 2025
Enhancing myeloablative fludarabine-busulfan conditioning with total marrow irradiation in high-risk myeloid diseaseFernando Molina, Alberto Mussetti, Anna Sureda
Hematology. American Society of Hematology. Education Program|December 9, 2023
CAR T-cell therapy in aggressive lymphomas-identifying prognostic and predictive markersAlberto Mussetti, Nicole Fabbri, Anna Sureda
Current Opinion in Infectious Diseases|July 18, 2022
COVID19 in hematological patients and telemedicine: lessons learned across Europe and the USAlberto Mussetti, Zinaida Peric, Cesar Figueroa
Leukemia & Lymphoma|August 14, 2012
Effective treatment of pomalidomide in central nervous system myelomatosisAlberto Mussetti, Serena Dalto, Vittorio Montefusco
Journal of Clinical Medicine|October 29, 2020
Allogeneic Hematopoietic Transplantation for Multiple Myeloma in the New Drugs Era: A Platform to CureAlberto Mussetti, Maria Queralt Salas, Vittorio Montefusco
Pageof 10